(Q57952153)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406648%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Serum proteomic signature for cystic fibrosis using an antibody microarray platform (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406648%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406648%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Meera Srivastava

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406648%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Ofer Eidelman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406648%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Catherine Jozwik

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406648%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Cloud Paweletz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406648%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Wei Huang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406648%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Harvey B Pollard

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406648%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

10 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406648%20AND%20SRC:MED&resulttype=core&format=json

Molecular Genetics and Metabolism

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406648%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406648%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406648%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

303-310

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406648%20AND%20SRC:MED&resulttype=core&format=json

Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Predictive 5-year survivorship model of cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Bedside multimarker testing for risk stratification in chest pain units: The chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST-elevation acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Up-regulation of ALG-2 in hepatomas and lung cancer tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Systemic inflammatory mediators and cystic fibrosis genotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Nasal wash as an alternative to bronchoalveolar lavage in detecting early pulmonary inflammation in children with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

A serum proteomic approach to gauging the state of remission in Wegener's granulomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

An array of possibilities for the study of autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Protein arrays for studying blood cells and their secreted products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Classification of human ovarian tumors using multivariate data analysis of polypeptide expression patterns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Clinical use of CA 125 and its combination assay with other tumor marker in patients with ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

High abundance protein profiling of cystic fibrosis lung epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Analysis of changes in acute-phase plasma proteins in an acute inflammatory response and in rheumatoid arthritis using two-dimensional gel electrophoresis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

The human plasma proteome: history, character, and diagnostic prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Serum proteomics profiling—a young technology begins to mature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Protein microarrays for gene expression and antibody screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Protein microarrays and proteomics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Digitoxin mimics gene therapy with CFTR and suppresses hypersecretion of IL-8 from cystic fibrosis lung epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Diabetes mellitus associated with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Mechanisms of insulin resistance in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Epidemiology of cystic fibrosis-related diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Liver disease in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Epidemiology of liver disease in cystic fibrosis: a longitudinal study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Proteome analysis on an early transformed human bronchial epithelial cell line, BEP2D, after alpha-particle irradiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Expression of maspin is up-regulated during the progression of mammary ductal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Modulation of cadherin and catenins expression by tumor necrosis factor-alpha and dexamethasone in human bronchial epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Hypoxia inducible factor-1 alpha expression in human normal and osteoarthritic chondrocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Regulation of interleukin-8 gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

The chemistry of signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Regulation of cortical structure by the ezrin-radixin-moesin protein family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Rho proteins play a critical role in cell migration during the early phase of mucosal restitution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Thrombophilia in children with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Prevalence of thrombophilia and catheter-related thrombosis in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Platelet hyperaggregability in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Plasma markers of platelet activation in cystic fibrosis liver and lung disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

Platelet activation in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.10.021

10.1016/J.YMGME.2005.10.021

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16406648%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference